ENSC Ensysce Biosciences Inc

Price (delayed)

$0.457

Market cap

$3.47M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.77

Enterprise value

$308,048

Highlights
The company's EPS has surged by 97% YoY and by 20% QoQ
Ensysce Biosciences's debt has plunged by 71% from the previous quarter
ENSC's net income has surged by 55% year-on-year but it is down by 9% since the previous quarter

Key stats

What are the main financial stats of ENSC
Market
Shares outstanding
7.59M
Market cap
$3.47M
Enterprise value
$308,048
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.89
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$9.94M
EBITDA
-$9.94M
Free cash flow
-$10.58M
Per share
EPS
-$3.77
Free cash flow per share
-$1.86
Book value per share
$0.51
Revenue per share
$0
TBVPS
$0.89
Balance sheet
Total assets
$5.07M
Total liabilities
$1.65M
Debt
$245,973
Equity
$3.75M
Working capital
$3.06M
Liquidity
Debt to equity
0.07
Current ratio
2.87
Quick ratio
2.14
Net debt/EBITDA
0.32
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-266.1%
Return on equity
-511.5%
Return on invested capital
N/A
Return on capital employed
-289.2%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ENSC stock price

How has the Ensysce Biosciences stock price performed over time
Intraday
-0.65%
1 week
-2.77%
1 month
-13.77%
1 year
-76.68%
YTD
-56.89%
QTD
-10.39%

Financial performance

How have Ensysce Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$10M
Net income
-$11.54M
Gross margin
N/A
Net margin
N/A
ENSC's net income has surged by 55% year-on-year but it is down by 9% since the previous quarter
Ensysce Biosciences's operating income has surged by 55% YoY and by 7% QoQ

Growth

What is Ensysce Biosciences's growth rate over time

Valuation

What is Ensysce Biosciences stock price valuation
P/E
N/A
P/B
0.89
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has surged by 97% YoY and by 20% QoQ

Efficiency

How efficient is Ensysce Biosciences business performance
ENSC's return on equity is up by 34% since the previous quarter
The company's return on assets rose by 32% YoY

Dividends

What is ENSC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ENSC.

Financial health

How did Ensysce Biosciences financials performed over time
Ensysce Biosciences's total assets has surged by 87% QoQ and by 30% YoY
The total liabilities has plunged by 59% YoY and by 51% from the previous quarter
Ensysce Biosciences's debt is 93% less than its equity
ENSC's debt to equity has soared by 103% QoQ but it is down by 36% YoY
Ensysce Biosciences's debt has plunged by 71% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.